Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Journal of Clinical Immunology
|
March 5, 2009
Abatacept does not induce direct gene expression changes in antigen-presenting cells
Julie A Carman, Patricia M Davis, Wen-Pin Yang, et al.
The Journal of Experimental Medicine
|
February 5, 2014
2B4 (CD244) induced by selective CD28 blockade functionally regulates allograft-specific CD8+ T cell responses
Danya Liu, Scott M Krummey, I Raul Badell, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 2, 2010
An LFA-1 (alphaLbeta2) small-molecule antagonist reduces inflammation and joint destruction in murine models of arthritis
Suzanne J Suchard, Dawn K Stetsko, Patricia M Davis, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 13, 2007
Design of LFA-1 antagonists based on a 2,3-dihydro-1H-pyrrolizin-5(7aH)-one scaffold
Dharmpal S Dodd, Steven Sheriff, ChiehYing J Chang, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 2, 2013
A monovalent anti-human CD28 domain antibody antagonist: preclinical efficacy and safety
Suzanne J Suchard, Patricia M Davis, Selena Kansal, et al.
Journal of Molecular Biology
|
May 25, 2016
Functional Antagonism of Human CD40 Achieved by Targeting a Unique Species-Specific Epitope
Aaron P Yamniuk, Anish Suri, Stanley R Krystek, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 8, 2015
Integrated Pharmacokinetic/Pharmacodynamic Analysis for Determining the Minimal Anticipated Biological Effect Level of a Novel Anti-CD28 Receptor Antagonist BMS-931699
Zheng Yang, Haiqing Wang, Theodora W Salcedo, et al.
Frontiers in Immunology
|
August 21, 2018
Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer
Nataly Manjarrez-Orduño, Laurence C Menard, Selena Kansal, et al.
JCI Insight
|
October 5, 2016
B cells from African American lupus patients exhibit an activated phenotype
Laurence C Menard, Sium Habte, Waldemar Gonsiorek, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 3, 2005
De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold
Dominique Potin, Michele Launay, Eric Nicolai, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Journal of Clinical Immunology
|
March 5, 2009
Abatacept does not induce direct gene expression changes in antigen-presenting cells
Julie A Carman, Patricia M Davis, Wen-Pin Yang, et al.
The Journal of Experimental Medicine
|
February 5, 2014
2B4 (CD244) induced by selective CD28 blockade functionally regulates allograft-specific CD8+ T cell responses
Danya Liu, Scott M Krummey, I Raul Badell, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 2, 2010
An LFA-1 (alphaLbeta2) small-molecule antagonist reduces inflammation and joint destruction in murine models of arthritis
Suzanne J Suchard, Dawn K Stetsko, Patricia M Davis, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 13, 2007
Design of LFA-1 antagonists based on a 2,3-dihydro-1H-pyrrolizin-5(7aH)-one scaffold
Dharmpal S Dodd, Steven Sheriff, ChiehYing J Chang, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 2, 2013
A monovalent anti-human CD28 domain antibody antagonist: preclinical efficacy and safety
Suzanne J Suchard, Patricia M Davis, Selena Kansal, et al.
Journal of Molecular Biology
|
May 25, 2016
Functional Antagonism of Human CD40 Achieved by Targeting a Unique Species-Specific Epitope
Aaron P Yamniuk, Anish Suri, Stanley R Krystek, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 8, 2015
Integrated Pharmacokinetic/Pharmacodynamic Analysis for Determining the Minimal Anticipated Biological Effect Level of a Novel Anti-CD28 Receptor Antagonist BMS-931699
Zheng Yang, Haiqing Wang, Theodora W Salcedo, et al.
Frontiers in Immunology
|
August 21, 2018
Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer
Nataly Manjarrez-Orduño, Laurence C Menard, Selena Kansal, et al.
JCI Insight
|
October 5, 2016
B cells from African American lupus patients exhibit an activated phenotype
Laurence C Menard, Sium Habte, Waldemar Gonsiorek, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 3, 2005
De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold
Dominique Potin, Michele Launay, Eric Nicolai, et al.
Page
of 7